Guixia Ding: Clinical Trials

1 trial sponsored by Guixia Ding, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Not yet recruiting 1

Follow Guixia Ding: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis
Telitacicept - IgA Nephropathy (IgAN), IgAVN
Phase 3Not yet recruitingGuixia Ding1242025-08-012025-07-10

Conditions studied

Glomerulonephritis, IGA (1)

Interventions

telitacicept (1)